(VIANEWS) – Shares of Sorrento Therapeutics (NASDAQ: SRNE) fell by a staggering 11.5% to $2.89 at 15:25 EST on Thursday, after five sequential sessions in a row of losses. NASDAQ is dropping 0.93% to $13,416.28, following the last session’s upward trend. This seems, as yet, a somewhat down trend exchanging session today.

Sorrento Therapeutics’s last close was $3.26, 81.1% under its 52-week high of $17.25.


Today’s last reported volume for Sorrento Therapeutics is 10227953 which is 69.16% above its average volume of 6045977.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is a negative 13.4% for the present quarter and 13% for the next. The company’s growth estimates for the ongoing quarter and the next is 30.3% and 14.8%, respectively.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 84.6%, now sitting on 46.52M for the twelve trailing months.


Sorrento Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.47%, a negative 1.59%, and a positive 3.60%, respectively.

Sorrento Therapeutics’s highest amplitude of average volatility was 6.47% (last week), 4.18% (last month), and 3.60% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sorrento Therapeutics’s stock is considered to be overbought (>=80).

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $2.89 at 15:25 EST, way under its 52-week low of $4.69.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s worth is way below its 50-day moving average of $6.36 and way under its 200-day moving average of $7.85.

More news about Sorrento Therapeutics (SRNE).


Please enter your comment!
Please enter your name here